| Όνομα | Μέγεθος | Ημερομηνία | ||
|---|---|---|---|---|
|
|
A1.pdf | 392.55 KB | 3/2/14, 11:29 π.μ. | |
|
|
AVRAMEAS 1991 Natural autoantibodies gnothi seauton.pdf | 625.87 KB | 3/2/14, 11:29 π.μ. | |
|
|
Cancer Immunoediting_2011.pdf | 305.65 KB | 27/1/14, 11:34 π.μ. | |
|
|
CARs in B-cell cancers_2013.pdf | 1.07 MB | 27/1/14, 11:34 π.μ. | |
|
|
Complement_immunosurveillance_review2010.pdf | 2.64 MB | 27/1/14, 11:35 π.μ. | |
|
|
Designing vaccines for the 21st century.pdf | 754.37 KB | 5/2/14, 1:38 μ.μ. | |
|
|
Gaitanaki 1_1.pdf | 954.27 KB | 27/1/14, 11:38 π.μ. | |
|
|
Gaitanaki 1_2.pdf | 1.06 MB | 27/1/14, 11:38 π.μ. | |
|
|
Gaitanaki 1_3.pdf | 1.62 MB | 27/1/14, 11:38 π.μ. | |
|
|
Gaitanaki 1_4.pdf | 784.85 KB | 27/1/14, 11:38 π.μ. | |
|
|
Gaitanaki 1_5.pdf | 59.2 KB | 27/1/14, 11:38 π.μ. | |
|
|
Gaitanaki 1.pdf | 391.94 KB | 27/1/14, 11:34 π.μ. | |
|
|
Gaitanaki 2.pdf | 694.75 KB | 27/1/14, 11:34 π.μ. | |
|
|
Gaitanaki 3.pdf | 92.37 KB | 27/1/14, 11:34 π.μ. | |
|
|
Immunogenic death and DAMPs_2013.pdf | 912.59 KB | 27/1/14, 11:35 π.μ. | |
|
|
Kinase inhibitors in therapy_2013.pdf | 319.51 KB | 27/1/14, 11:35 π.μ. | |
|
|
LYMBERI 2007 Natural occuring B cell autoreactivity.pdf | 528.47 KB | 3/2/14, 11:30 π.μ. | |
|
|
mcab1.pdf | 577.59 KB | 4/3/14, 10:15 π.μ. | |
|
|
McAb2.pdf | 1.16 MB | 4/3/14, 10:15 π.μ. | |
|
|
McAb3.pdf | 593.85 KB | 4/3/14, 10:15 π.μ. | |
|
|
McAb4.pdf | 1.1 MB | 4/3/14, 10:15 π.μ. | |
|
|
NODS_NAPLs_review2005.pdf | 171.55 KB | 27/1/14, 11:36 π.μ. | |
|
|
PD1, PDL1 antibodies_2013.pdf | 485.46 KB | 27/1/14, 11:36 π.μ. | |
|
|
PRRs against pathogens_2013.pdf | 1.3 MB | 27/1/14, 11:37 π.μ. | |
|
|
The yin and yang of viruses and interferons 2012.pdf | 708.37 KB | 5/2/14, 1:38 μ.μ. | |
|
|
TLRs_AkiraReview2010.pdf | 779.22 KB | 27/1/14, 11:37 π.μ. | |
|
|
Vaccination for hepatitis C-Klenerman.pdf | 4.2 MB | 5/2/14, 1:38 μ.μ. | |
|
|
VLPs based human vaccines 2013.pdf | 3.34 MB | 5/2/14, 1:38 μ.μ. | |
|
|
ματικά Αυτοάνοσ α Νοσήματα 2014.pdf | 852.36 KB | 3/2/14, 11:30 π.μ. |